Literature DB >> 11702207

DNA sequence comparison of human and mouse retinitis pigmentosa GTPase regulator (RPGR) identifies tissue-specific exons and putative regulatory elements.

R Kirschner1, D Erturk, C Zeitz, S Sahin, J Ramser, F P Cremers, H H Ropers, W Berger.   

Abstract

Retinitis pigmentosa 3 (RP3) is a progressive retinal degeneration due to mutations in the X-linked RPGR gene. Transcription studies in human and mouse tissues have revealed ubiquitously expressed transcripts and also an exceptional high number of tissue-specific alternative splice variants. However, regulation of tissue-specific expression and splicing is unclear, but this is of particular interest as mutations in this ubiquitously expressed gene lead to severe retinal degeneration, while other tissues are unaffected. To elucidate the conservation pattern of RPGR and to identify additional tissue-specific exons and putative regulatory elements we performed comparative genomic sequencing of the human and mouse RPGR gene. Each of the genes spans a region of nearly 59 kb, and all previously identified exons are conserved between the two species. DNA sequence comparison identified 28 conserved sequence elements (CSEs) in introns, upstream of exon 1, within the promotor region, and downstream of the most 3' exon. Some of the intronic CSEs flank tissue-specific exons and therefore may represent important regulatory elements for alternative splicing. Comparative northern blot hybridization of ubiquitous and tissue-specific RPGR probes identified high molecular weight transcripts with similar expression patterns in both human and mouse. These transcripts range from 6 to 15 kb in size and suggest the presence of additional transcribed sequences within RPGR. Our cross-species sequence comparison enables us to define candidate regions that may explain these large transcripts and will therefore contribute to the understanding of RPGR expression and splicing.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11702207     DOI: 10.1007/s004390100572

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  4 in total

1.  A comprehensive mutation analysis of RP2 and RPGR in a North American cohort of families with X-linked retinitis pigmentosa.

Authors:  Debra K Breuer; Beverly M Yashar; Elena Filippova; Suja Hiriyanna; Robert H Lyons; Alan J Mears; Bersabell Asaye; Ceren Acar; Raf Vervoort; Alan F Wright; Maria A Musarella; Patricia Wheeler; Ian MacDonald; Alessandro Iannaccone; David Birch; Dennis R Hoffman; Gerald A Fishman; John R Heckenlively; Samuel G Jacobson; Paul A Sieving; Anand Swaroop
Journal:  Am J Hum Genet       Date:  2002-04-30       Impact factor: 11.025

Review 2.  Molecular Strategies for RPGR Gene Therapy.

Authors:  Jasmina Cehajic Kapetanovic; Michelle E McClements; Cristina Martinez-Fernandez de la Camara; Robert E MacLaren
Journal:  Genes (Basel)       Date:  2019-09-04       Impact factor: 4.096

3.  Identification of novel mutations in X-linked retinitis pigmentosa families and implications for diagnostic testing.

Authors:  John Neidhardt; Esther Glaus; Birgit Lorenz; Christian Netzer; Yün Li; Maria Schambeck; Mariana Wittmer; Silke Feil; Renate Kirschner-Schwabe; Thomas Rosenberg; Frans P M Cremers; Arthur A B Bergen; Daniel Barthelmes; Husnia Baraki; Fabian Schmid; Gaby Tanner; Johannes Fleischhauer; Ulrike Orth; Christian Becker; Erika Wegscheider; Gudrun Nürnberg; Peter Nürnberg; Hanno Jörn Bolz; Andreas Gal; Wolfgang Berger
Journal:  Mol Vis       Date:  2008-06-06       Impact factor: 2.367

4.  Precision Medicine: Genetic Repair of Retinitis Pigmentosa in Patient-Derived Stem Cells.

Authors:  Alexander G Bassuk; Andrew Zheng; Yao Li; Stephen H Tsang; Vinit B Mahajan
Journal:  Sci Rep       Date:  2016-01-27       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.